| Regeneration and orthotopic transplantation of a bioartificial lung HC Ott, B Clippinger, C Conrad, C Schuetz, I Pomerantseva, L Ikonomou, ... Nature medicine 16 (8), 927-933, 2010 | 1335 | 2010 |
| Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene D Zhou, C Conrad, F Xia, JS Park, B Payer, Y Yin, GY Lauwers, W Thasler, ... Cancer cell 16 (5), 425-438, 2009 | 1045 | 2009 |
| STAT3 Plays a Critical Role in KRAS-Induced Pancreatic Tumorigenesis RB Corcoran, G Contino, V Deshpande, A Tzatsos, C Conrad, CH Benes, ... Cancer research 71 (14), 5020-5029, 2011 | 486 | 2011 |
| The Miami international evidence-based guidelines on minimally invasive pancreas resection HJ Asbun, AL Moekotte, FL Vissers, F Kunzler, F Cipriani, A Alseidi, ... Annals of surgery 271 (1), 1-14, 2020 | 376 | 2020 |
| The North American Neuroendocrine Tumor Society consensus paper on the surgical management of pancreatic neuroendocrine tumors JR Howe, NB Merchant, C Conrad, XM Keutgen, J Hallet, JA Drebin, ... Pancreas 49 (1), 1-33, 2020 | 315 | 2020 |
| Parenchymal-sparing hepatectomy in colorectal liver metastasis improves salvageability and survival Y Mise, TA Aloia, KW Brudvik, L Schwarz, JN Vauthey, C Conrad Annals of surgery 263 (1), 146-152, 2016 | 296 | 2016 |
| Hepatic portal venous gas: the ABCs of management AL Nelson, TM Millington, D Sahani, RT Chung, C Bauer, M Hertl, ... Archives of Surgery 144 (6), 575-581, 2009 | 266 | 2009 |
| Overture for growth hormone: requiem for interleukin-6? C Conrad, H Niess, KW Jauch, CJ Bruns, WH Hartl, L Welker Critical care medicine 35 (12), 2709-2713, 2007 | 249 | 2007 |
| Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study J Shindoh, X De Aretxabala, TA Aloia, JC Roa, I Roa, G Zimmitti, M Javle, ... Annals of surgery 261 (4), 733-739, 2015 | 245 | 2015 |
| Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis S Huber, CJ Bruns, G Schmid, PC Hermann, C Conrad, H Niess, R Huss, ... Kidney international 71 (8), 771-777, 2007 | 238 | 2007 |
| Targeting tumor stroma using engineered mesenchymal stem cells reduces the growth of pancreatic carcinoma C Zischek, H Niess, I Ischenko, C Conrad, R Huss, KW Jauch, PJ Nelson, ... Annals of surgery 250 (5), 747-753, 2009 | 223 | 2009 |
| RAS mutation clinical risk score to predict survival after resection of colorectal liver metastases KW Brudvik, RP Jones, F Giuliante, J Shindoh, G Passot, MH Chung, ... Annals of surgery 269 (1), 120-126, 2019 | 221 | 2019 |
| Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series KE Lunsford, M Javle, K Heyne, RT Shroff, R Abdel-Wahab, N Gupta, ... The lancet Gastroenterology & hepatology 3 (5), 337-348, 2018 | 220 | 2018 |
| Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases KW Brudvik, SE Kopetz, L Li, C Conrad, TA Aloia, JN Vauthey Journal of British Surgery 102 (10), 1175-1183, 2015 | 215 | 2015 |
| Return to intended oncologic treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy TA Aloia, G Zimmitti, C Conrad, V Gottumukalla, S Kopetz, JN Vauthey Journal of surgical oncology 110 (2), 107-114, 2014 | 212 | 2014 |
| Multipotent mesenchymal stem cells acquire a lymphendothelial phenotype and enhance lymphatic regeneration in vivo C Conrad, H Niess, R Huss, S Huber, I Von Luettichau, PJ Nelson, HC Ott, ... Circulation 119 (2), 281-289, 2009 | 199 | 2009 |
| Characterization of anthropometric changes that occur during neoadjuvant therapy for potentially resectable pancreatic cancer AB Cooper, R Slack, D Fogelman, HM Holmes, M Petzel, N Parker, ... Annals of surgical oncology 22, 2416-2423, 2015 | 173 | 2015 |
| Adult stem cell lines in regenerative medicine and reconstructive surgery C Conrad, R Huss Journal of Surgical Research 124 (2), 201-208, 2005 | 168 | 2005 |
| Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of … H Niess, Q Bao, C Conrad, C Zischek, M Notohamiprodjo, F Schwab, ... Annals of surgery 254 (5), 767-775, 2011 | 159 | 2011 |
| Ninety-day postoperative mortality is a legitimate measure of hepatopancreatobiliary surgical quality Y Mise, JN Vauthey, G Zimmitti, NH Parker, C Conrad, TA Aloia, JE Lee, ... Annals of surgery 262 (6), 1071-1078, 2015 | 147 | 2015 |
